Literature DB >> 25271655

Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders.

Tae Woo Park1, Peter D Friedmann2.   

Abstract

Substance use disorders are a leading cause of morbidity and mortality in the United States. Medications for the treatment of substance use disorders are effective yet underutilized. This article reviews recent literature examining medications used for the treatment of alcohol and opioid use disorders. The neurobehavioral rationale for medication treatment and the most common ways medications work in the treatment of substance use disorders are discussed. Finally, the medications and the evidence behind their effectiveness are briefly reviewed. Physicians and other prescribing clinicians should take an active role in facilitating remission and recovery from substance use disorders by prescribing these effective medications with brief medical management counseling.

Entities:  

Keywords:  Substance use disorders; addiction; addiction treatment; medication

Mesh:

Substances:

Year:  2014        PMID: 25271655      PMCID: PMC4406629     

Source DB:  PubMed          Journal:  R I Med J (2013)        ISSN: 0363-7913


  26 in total

Review 1.  Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis.

Authors:  Antonio-Javier Chamorro; Miguel Marcos; José-Antonio Mirón-Canelo; Isabel Pastor; Rogelio González-Sarmiento; Francisco-Javier Laso
Journal:  Addict Biol       Date:  2012-05       Impact factor: 4.280

Review 2.  Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies.

Authors:  Louisa Degenhardt; Chiara Bucello; Bradley Mathers; Christina Briegleb; Hammad Ali; Matt Hickman; Jennifer McLaren
Journal:  Addiction       Date:  2010-11-04       Impact factor: 6.526

Review 3.  Oral naltrexone maintenance treatment for opioid dependence.

Authors:  Silvia Minozzi; Laura Amato; Simona Vecchi; Marina Davoli; Ursula Kirchmayer; Annette Verster
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

4.  Naltrexone and nalmefene: any meaningful difference?

Authors:  Robert M Swift
Journal:  Biol Psychiatry       Date:  2013-04-15       Impact factor: 13.382

Review 5.  The efficacy of disulfiram for the treatment of alcohol use disorder.

Authors:  Charlotte H Jørgensen; Bolette Pedersen; Hanne Tønnesen
Journal:  Alcohol Clin Exp Res       Date:  2011-05-25       Impact factor: 3.455

6.  Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence.

Authors:  Alex H S Harris; Elizabeth Oliva; Thomas Bowe; Keith N Humphreys; Daniel R Kivlahan; Jodie A Trafton
Journal:  Psychiatr Serv       Date:  2012-07       Impact factor: 3.084

7.  QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel.

Authors:  Judith A Martin; Anthony Campbell; Thomas Killip; Margaret Kotz; Mori J Krantz; Mary Jeanne Kreek; Brian A McCarroll; Davendra Mehta; J Thomas Payte; Barry Stimmel; Trusandra Taylor; Mark C P Haigney; Bonnie B Wilford
Journal:  J Addict Dis       Date:  2011-10

8.  Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data.

Authors:  Barbara J Mason; Philippe Lehert
Journal:  Alcohol Clin Exp Res       Date:  2011-09-06       Impact factor: 3.455

Review 9.  Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis.

Authors:  Georgie J MacArthur; Silvia Minozzi; Natasha Martin; Peter Vickerman; Sherry Deren; Julie Bruneau; Louisa Degenhardt; Matthew Hickman
Journal:  BMJ       Date:  2012-10-03

10.  Just call it "treatment".

Authors:  Peter D Friedmann; Robert P Schwartz
Journal:  Addict Sci Clin Pract       Date:  2012-06-09
View more
  3 in total

1.  Increasing Prevalence of Alcohol Use Disorders: Meeting the Challenge in Primary Care : Commentary on Williams et al., Barriers to and Facilitators of Alcohol Use Disorder Pharmacotherapy in Primary Care: A Qualitative Study in Five VA Clinics.

Authors:  Barbara J Turner; Charles W Mathias
Journal:  J Gen Intern Med       Date:  2018-03       Impact factor: 5.128

2.  A Needs Assessment of the Number of Comprehensive Addiction Care Physicians Required in a Canadian Setting.

Authors:  Jasmine McEachern; Keith Ahamad; Seonaid Nolan; Annabel Mead; Evan Wood; Jan Klimas
Journal:  J Addict Med       Date:  2016 Jul-Aug       Impact factor: 3.702

3.  Surgeons' Perspectives on Valve Surgery in People With Drug Use-Associated Infective Endocarditis.

Authors:  Alysse G Wurcel; Julia Zubiago; Jessica Reyes; Emma Smyth; Keki R Balsara; Danielle Avila; Joshua A Barocas; Curt G Beckwith; Jenny Bui; Cody A Chastain; Ellen F Eaton; Simeon Kimmel; Molly L Paras; Asher J Schranz; Darshali A Vyas; Alison Rapoport
Journal:  Ann Thorac Surg       Date:  2022-01-31       Impact factor: 5.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.